Advanced Medical Solutions Group (LON:AMS) Earns Buy Rating from Berenberg Bank

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating restated by Berenberg Bank in a research note issued to investors on Tuesday,Digital Look reports. They currently have a GBX 300 ($3.67) price objective on the stock. Berenberg Bank’s target price suggests a potential upside of 37.61% from the company’s current price.

Advanced Medical Solutions Group Stock Up 14.4 %

Shares of Advanced Medical Solutions Group stock traded up GBX 27.40 ($0.34) during midday trading on Tuesday, reaching GBX 218 ($2.67). 1,169,792 shares of the company’s stock traded hands, compared to its average volume of 483,901. The company has a market cap of £467.72 million, a price-to-earnings ratio of 4,360.00, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company’s 50 day simple moving average is GBX 204.23 and its 200 day simple moving average is GBX 220.08. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. Advanced Medical Solutions Group has a 52 week low of GBX 176.60 ($2.16) and a 52 week high of GBX 275.83 ($3.38).

Insider Buying and Selling

In other news, insider Eddie Johnson sold 34,235 shares of Advanced Medical Solutions Group stock in a transaction dated Monday, November 11th. The shares were sold at an average price of GBX 218 ($2.67), for a total transaction of £74,632.30 ($91,326.85). Insiders own 3.12% of the company’s stock.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.